Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02650583 · ClinicalTrials.gov registry record · NA
Enhancing Connections Program in Improving Communication Between Patients With Incurable Cancer and Their Children
A NA study of Advanced Malignant Neoplasm, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT02650583: Completed NA study of Advanced Malignant Neoplasm, sponsored by University of Washington.
NCT02650583 is a NA study of Advanced Malignant Neoplasm that has completed, run by University of Washington. The registered enrollment target is 41 participants, below the 174-participant average among 16 other Advanced Malignant Neoplasm trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02650583, a NA study of Advanced Malignant Neoplasm, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot clinical trial studies the use of the Enhancing Connections Program in improving communication between patients with incurable cancer and their children. The Enhancing Connections Program is an educational program that may provide patients with new competencies to improve communication with their children and help them to cope with their parent's incurable cancer.
Primary Outcome
Baseline scores will be compared with post-intervention scores on the same measures. Analysis of covariance will be used to test for significant differences between pre- and post-test scores.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Educational Intervention
Study Locations (1)
Washington
- Fred Hutch/University of Washington Cancer Consortium - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2015-12-28 |
| Est. Completion | 2018-02-15 |
| Phase | NA |
What the finished NCT02650583 record still lists
NCT02650583 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 174-participant average among 16 other Advanced Malignant Neoplasm trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Advanced Malignant Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT02650583 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT02650583 about?
NCT02650583 is a clinical study titled "Enhancing Connections Program in Improving Communication Between Patients With Incurable Cancer and Their Children". This pilot clinical trial studies the use of the Enhancing Connections Program in improving communication between patients with incurable cancer and their children. The Enhancing Connections Program is an educational program that may provide patients with new competencies to improve communication wi...
What is the current status of trial NCT02650583?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2015-12-28. Estimated completion is 2018-02-15.
What conditions does trial NCT02650583 study?
This clinical trial studies the following conditions: Advanced Malignant Neoplasm.
What interventions are being tested in trial NCT02650583?
The interventions under investigation include: Questionnaire Administration (OTHER), Educational Intervention (OTHER).
Who is sponsoring clinical trial NCT02650583?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02650583 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02650583's enrollment target sits among peer trials
41 15th of 16 higher than 2 of 16 other Advanced Malignant Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Advanced Malignant Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center
ACTIVE NOT RECRUITING · NA
-
Cordotomy in Reducing Pain in Patients With Advanced Cancer
ACTIVE NOT RECRUITING · NA
-
RCT of QPS vs General Information Sheet
ACTIVE NOT RECRUITING · NA
-
Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits
COMPLETED · NA
-
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RECRUITING · Phase 1
-
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI